Sanofi is a global leader in healthcare and pharmaceuticals based in Paris, France. In 2023, Sanofi generated over 43 billion euros in revenues, the highest so far. In general, the company’s revenues have been increasing since 2006 when their revenues were 28.4 billion euros.
Sanofi’s company profile
Sanofi is a one of the world’s leading pharmaceutical companies and its subsidiaries include Genzyme and Sanofi Pasteur, to name a few. Sanofi is no longer ranked among the top 10 global pharmaceutical companies based on market capitalization (as of October 2023). However, the company is ranked among the top 10 global pharmaceutical companies based on its prescription sales.
Sanofi’s products and revenues
Sanofi works in several therapeutic sectors including diabetes and cardiovascular diseases, oncology, immunology, multiple sclerosis, rare diseases, rare blood disorders, and vaccines. A majority of Sanofi’s revenues can be attributed to their pharmaceutical sector. Sanofi’s top pharmaceutical products, based on revenues include Dupixent, Lantus, and Lovenox . Lantus is a long-acting insulin for use in type I and type II diabetes. Sanofi also used to have an animal health sector but the business was sold to Boehringer Ingelheim in 2016.
Revenue of Sanofi from 2006 to 2023
(in million euros)
Figures for 2006-2021 were quoted from previous annual reports.
* Including the Animal Health business, the net income/loss of which is presented in a separate line item. For 2012 and 2011, it is not practicable to provide information excluding the Animal Health business without
unreasonable effort or expense.
** Due to a change in accounting presentation, VaxServe sales of non-Sanofi products are included in Other revenues from 2016 onwards. The presentation of prior period Net sales and Other revenues has been amended accordingly.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Sanofi. (February 23, 2024). Revenue of Sanofi from 2006 to 2023 (in million euros) [Graph]. In Statista. Retrieved November 10, 2024, from https://www-statista-com.ezproxy.canberra.edu.au/statistics/266509/revenue-of-sanofi-since-2006/
Sanofi. "Revenue of Sanofi from 2006 to 2023 (in million euros)." Chart. February 23, 2024. Statista. Accessed November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/266509/revenue-of-sanofi-since-2006/
Sanofi. (2024). Revenue of Sanofi from 2006 to 2023 (in million euros). Statista. Statista Inc.. Accessed: November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/266509/revenue-of-sanofi-since-2006/
Sanofi. "Revenue of Sanofi from 2006 to 2023 (in Million Euros)." Statista, Statista Inc., 23 Feb 2024, https://www-statista-com.ezproxy.canberra.edu.au/statistics/266509/revenue-of-sanofi-since-2006/
Sanofi, Revenue of Sanofi from 2006 to 2023 (in million euros) Statista, https://www-statista-com.ezproxy.canberra.edu.au/statistics/266509/revenue-of-sanofi-since-2006/ (last visited November 10, 2024)
Revenue of Sanofi from 2006 to 2023 (in million euros) [Graph], Sanofi, February 23, 2024. [Online]. Available: https://www-statista-com.ezproxy.canberra.edu.au/statistics/266509/revenue-of-sanofi-since-2006/
